Mid and Long-term Results of Endovascular Treatment of Thoracic Penetrating Aortic Ulcers

Endovascular treatment for penetrating ulcers of the thoracic aorta demonstrates favorable short and long-term outcomes, with high technical success and low aorta/procedure related mortality.Clinical ImpactThis study reinforces TEVAR as a safe and effective first-line therapy for penetrating aortic ulcers, offering clinicians strong long-term data to support decision-making in a high-risk, elderly population. The findings underscore that most PAUs can be treated with limited aortic coverage and minimal adjunctive procedures, reducing procedural complexity and morbidity. The extended follow-up-among the longest reported-highlights durable aortic exclusion, while emphasizing the importance of lifelong imaging due to endoleak-related reinterventions.